Company intelligence / Profile preview

AB OVO

Belgrade, Serbia

Ownership: Private
Development stage: Other

Overview

AB OVO markets wound healing, burn care, and health-related products, including SILBEN nano repair (kaolin-based), BurnFree, and Medihoney (medical-grade Manuka honey). Clinical results referenced are positive for wound healing and antibacterial action, but are not presented as formal clinical trial data.

Therapeutic areas: Women's HealthDermatology
Modalities: Medical deviceSmall moleculeBiologicFood supplement
Industry: Consumable Medical Devices

Partnerships

Epsilon Health Medicals (Greece)Derma Sciences (UK)NTC s.r.l. (Italy)PIETRASANTA PHARMA Spa (Italy)Gruppo Farmaimpresa s.r.l. (Italy)OFM, LLC (Russia)Nirial Pharma Srl (Italy)Laboratoires INELDEA (France)

Beyond the preview

Go deeper on AB OVO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AB OVO.

Explore the full profile